|Home||» Products||» Pharmaceutical Intermediates||» Axitinib Intermediates|
Axitinib Intermediates are required for formulation of a drug which is intended to be used for clinical trials of renal cell carcinoma & for inhibition of growth of cancer cells. Axitinib is a type of tyrosine kinase inhibitor having molecular formula C22H18N4OS with molar mass of 386.469 g/mol. We offer various intermediates for its formulation including 6-Iodo-1H-indazole, 2-Mercapto-N-methylbenzamide, and 3-Iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole. Axitinib Intermediates provided by us are admired for having up to 99% of purity with good stability.